PAVURUTAMAB

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 15:00:24 GMT 2023` Edited by `admin` on `Sat Dec 16 15:00:24 GMT 2023`
Protein Type	FC FUSION PROTEIN
Protein Sub Type	BISPECIFIC T CELL ENGAGER
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	GLR3JG8TZU
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

PAVURUTAMAB

Official Name

English

PAVURUTAMAB [USAN]

Common Name

English

AMG701

Code

English

ANTI-BCMA X ANTI-CD3 BITE AMG 701

Common Name

English

AMG-701

Code

English

IMMUNOGLOBULIN SCFV-SCFV-SCFC, ANTI-(HOMO SAPIENS TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 17 (B-CELL MATURATION PROTEIN, CD269_ANTIGEN)) TNR17 AND ANTI-(HOMO SAPIENS T-CELL SURFACE GLYCOPROTEIN CD3 EPSILON CHAIN (T-CELL SURFACE ANTIGEN T3/LEU-4

Common Name

English

BCMA/CD3-DIRECTED BISPECIFIC T-CELL ENGAGER ANTIBODY AMG 701

Common Name

English

IMMUNOGLOBULIN, ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY PROTEIN TNFRSF17) (HUMAN MONOCLONAL BRA-HWZV 1 SINGLE-CHAIN VARIABLE FRAGMENT VH1-(GGGGS)3-VL1) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUM

Common Name

English

Pavurutamab [WHO-DD]

Common Name

English

pavurutamab [INN]

Common Name

English

ANTI-BCMA X ANTI-CD3 BITE (BISPECIFIC T CELL ENGAGER) ANTIBODY CONSTRUCT

Common Name

English

ANTI-BCMA/CD3 BITE ANTIBODY AMG 701

Common Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

669618